12. Business Combinations (Tables)

12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Proforma information

	For the Year Ended December 31, 2015
		Rennova Health, Inc. Historical			CollabRx, Inc. (a)			Pro-Forma Adjustments			Combined
Net Revenues	$	18,393,038		$	425,000		$	–		$	18,818,038
Operating Expenses		63,858,012			4,881,000			–			67,507,045
Income (Loss) from operations		(45,464,974	)		(4,456,000	)		–			(48,689,007	)
Other income (expense)		474,215			(43,000	)		–			431,215
Income (Loss) before income taxes		(44,990,759	)		(4,499,000	)		–			(48,257,792	)
Provision for income taxes		(9,028,253	)		(269,000	)		–	(b)		(9,297,253	)
Net income (loss) attributable to Rennova Health		(35,962,506	)		(4,230,000	)		–			(38,960,539	)
Preferred stock dividends		1,627,188			–			(1,627,188	)(c)		–
Net income (loss) attributable to Rennova Health common shareholders	$	(37,589,694	)	$	(4,230,000	)	$	1,627,188		$	(38,960,539	)
Net income (loss) per common share:
Basic	$	(90.46	)							$	(87.88	)
Diluted	$	(90.46	)							$	(87.88	)
Weighted average number of common shares outstanding during the period:
Basic		415,517									443,322
Diluted		415,517									443,322

_______________

(a) Reflects 2015 and 2014 results of operations prior to the acquisition dates. Clinlab was acquired on March 18, 2014, Epinex was acquired on August 26, 2014 and CollabRx was acquired on November 2, 2015. For the year ended December 31, 2014, CollabRx is included using its fiscal year ended March 31, 2015 financial statements.

(b) Reflects changes in taxes, if any, resulting from including the aggregate net losses of acquired operations in the corporate tax return.

(c) Reflects elimination of preferred stock dividend accruals resulting from the reverse merger with CollabRx.

CollabRx [Member]

Consideration allocation for acquisitions

Cash	$	4,737,773
Accounts receivable		54,675
Other current assets		105,700
Property and equipment		92,636
Accounts payable and accrued expenses		(1,620,000	)
Deferred revenue		(123,000	)
Other liabilities		(520,070	)
Derivative liabilities		(1,578,976	)
Identifiable intangible assets		170,000
Total identifiable net assets		1,318,738
Goodwill		12,192,039
Total consideration	$	13,510,777